Serum Amyloid A Level in Egyptian Children with Familial Mediterranean Fever

Table 4

Correlation between colchicine treatment and SAA level.

Colchicine treatment	⁢SAA level
	Low level (<30 mg/L); ()	High level (≥30 mg/L); ()
Duration of colchicine treatment	2.0 ± 1.56 years	1.86 ± 1.83 years
Colchicine dosage
Low dose (<1.5 mg/day)	10 patients (18.9%)	43 patients (81.1%)
High dose (≥1.5 mg/day)	5 patients (27.8%)	13 patients (72.2%)
Adherence to colchicine	7 patients (18%)	32 patients (82%)

Note: () = number of patients.